{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T19:30:12Z","timestamp":1780515012286,"version":"3.54.1"},"reference-count":48,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1097\/mca.0000000000000414","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T16:31:28Z","timestamp":1472056288000},"page":"77-89","source":"Crossref","is-referenced-by-count":7,"title":["Bioresorbable vascular scaffolds for the treatment of coronary artery disease"],"prefix":"10.1097","volume":"28","author":[{"given":"David G.","family":"Rizik","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Hermiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A.","family":"Simonton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin J.","family":"Klassen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dean J.","family":"Kereiakes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-13-20210204","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2012.05.093","article-title":"Bioresorbable scaffolds: current knowledge, potentialities and limitations experienced during their first clinical applications","volume":"167","author":"Bourantas","year":"2013","journal-title":"Int J Cardiol"},{"key":"R2-13-20210204","doi-asserted-by":"crossref","first-page":"3198","DOI":"10.1161\/CIRCULATIONAHA.108.826479","article-title":"Safety and efficacy of drug-eluting and bare metal stents: comprehensive meta-analysis of randomized trials and observational studies","volume":"119","author":"Kirtane","year":"2009","journal-title":"Circulation"},{"key":"R3-13-20210204","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1056\/NEJMra051091","article-title":"Coronary-artery stents","volume":"354","author":"Serruys","year":"2006","journal-title":"N Engl J Med"},{"key":"R4-13-20210204","doi-asserted-by":"crossref","first-page":"2873","DOI":"10.1161\/CIRCULATIONAHA.112.097014","article-title":"Short- and long-term outcomes with drug-eluting and bare-metal coronary stents: a mixed-treatment comparison analysis of 117\u2009762 patient-years of follow-up from randomized trials","volume":"125","author":"Bangalore","year":"2012","journal-title":"Circulation"},{"key":"R5-13-20210204","first-page":"407","article-title":"Optimizing vessel healing following drug eluting stent implantation with biodegradable polymer DES","volume":"62","author":"Cerrato","year":"2014","journal-title":"Minerva Cardioangiol"},{"key":"R6-13-20210204","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.jcin.2016.02.025","article-title":"Incidence and clinical outcomes of stent fractures based on 6555 patients and 16\u2009482 drug-eluting stents from four centers","volume":"9","author":"Kan","year":"2016","journal-title":"JACC Cardiovasc Intv"},{"key":"R7-13-20210204","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1016\/S0140-6736(15)60657-2","article-title":"Percutaneous coronary interventional strategies for treatment of in-stent restenosis: a network meta-analysis","volume":"386","author":"Siontis","year":"2015","journal-title":"Lancet"},{"key":"R8-13-20210204","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(12)60324-9","article-title":"Stent thrombosis with drug-eluting and bare-metal stents: evidence from a comprehensive network meta-analysis","volume":"379","author":"Palmerini","year":"2012","journal-title":"Lancet"},{"key":"R9-13-20210204","doi-asserted-by":"crossref","first-page":"g6427","DOI":"10.1136\/bmj.g6427","article-title":"Effects of cobalt-chromium everolimus eluting stents or bare metal stent on fatal and non-fatal cardiovascular events: patient level meta-analysis","volume":"349","author":"Valgimigli","year":"2014","journal-title":"BMJ"},{"key":"R10-13-20210204","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1016\/j.jcin.2013.05.005","article-title":"Meta-analysis of everolimus-eluting versus paclitaxel-eluting stents in coronary artery disease: final 3-year results of the SPIRIT clinical trials program (Clinical Evaluation of the Xience V Everolimus Eluting Coronary Stent System in the Treatment of Patients With De Novo Native Coronary Artery Lesions)","volume":"6","author":"Dangas","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R11-13-20210204","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1161\/CIRCULATIONAHA.116.021539","article-title":"Bioresorbable vascular scaffolds for coronary revascularization","volume":"134","author":"Kereiakes","year":"2016","journal-title":"Circulation"},{"key":"R12-13-20210204","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jacc.2006.03.042","article-title":"Pathology of drug-eluting stents in humans: delayed healing and late thrombotic risk","volume":"48","author":"Joner","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"R13-13-20210204","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.jacc.2011.01.011","article-title":"The pathology of neoatherosclerosis in human coronary implants bare-metal and drug-eluting stents","volume":"57","author":"Nakazawa","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"R14-13-20210204","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/CIRCULATIONAHA.113.001790","article-title":"Pathology of second-generation everolimus-eluting stents versus first-generation sirolimus- and paclitaxel-eluting stents in humans","volume":"129","author":"Otsuka","year":"2014","journal-title":"Circulation"},{"key":"R15-13-20210204","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1016\/j.ahj.2015.07.013","article-title":"Evaluation of a fully bioresorbable vascular scaffold in patients with coronary artery disease: design of and rationale for the ABSORB III randomized trial","volume":"170","author":"Kereiakes","year":"2015","journal-title":"Am Heart J"},{"key":"R16-13-20210204","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1002\/ccd.26172","article-title":"The ABSORB bioresorbable vascular scaffold: a novel, fully resorbable drug-eluting stent: current concepts and overview of clinical evidence","volume":"86","author":"Rizik","year":"2015","journal-title":"Catheter Cardiovasc Interv"},{"key":"R17-13-20210204","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijcard.2015.07.101","article-title":"Absorb bioresorbable vascular scaffold: what have we learned after 5 years of clinical experience?","volume":"201","author":"Caiazzo","year":"2015","journal-title":"Int J Cardiol"},{"key":"R18-13-20210204","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.jcin.2013.05.017","article-title":"Five-year clinical and functional multislice computed tomography angiographic results after coronary implantation of the fully resorbable polymeric everolimus-eluting scaffold in patients with de novo coronary artery disease: the ABSORB cohort A trial","volume":"6","author":"Onuma","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"R19-13-20210204","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.4244\/EIJV9I11A217","article-title":"Dynamics of vessel wall changes following the implantation of the absorb everolimus-eluting bioresorbable vascular scaffold: a multi-imaging modality study at 6, 12, 24 and 36 months","volume":"9","author":"Serruys","year":"2014","journal-title":"EuroIntervention"},{"key":"R20-13-20210204","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.4244\/EIJV10I12A243","article-title":"The ABSORB EXTEND study: preliminary report of the twelve-month clinical outcomes in the first 512 patients enrolled","volume":"10","author":"Abizaid","year":"2015","journal-title":"EuroIntervention"},{"key":"R21-13-20210204","doi-asserted-by":"crossref","first-page":"B179","DOI":"10.1016\/j.jacc.2014.07.679","article-title":"ABSORB FIRST: an interim report on baseline characteristics and acute performance on the first 1200 patients from a prospective, multi-center, global registry","volume":"64","author":"Eeckhout","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R22-13-20210204","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.4244\/EIJY14M07_11","article-title":"Percutaneous coronary intervention with everolimus-eluting bioresorbable vascular scaffolds in routine clinical practice: early and midterm outcomes from the European multicentre GHOST-EU registry","volume":"10","author":"Capodanno","year":"2015","journal-title":"EuroIntervention"},{"key":"R23-13-20210204","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.4244\/EIJY14M08_08","article-title":"Initial experience and clinical evaluation of the Absorb bioresorbable vascular scaffold (BVS) in real-world practice: the AMC Single Centre Real World PCI Registry","volume":"10","author":"Kraak","year":"2015","journal-title":"EuroIntervention"},{"key":"R24-13-20210204","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.5603\/KP.a2014.0147","article-title":"Use of bioresorbable vascular scaffolds in patients with stable angina and acute coronary syndromes. Polish National Registry","volume":"72","author":"Rzeszutko","year":"2014","journal-title":"Kardiol Pol"},{"key":"R25-13-20210204","doi-asserted-by":"crossref","first-page":"149","DOI":"10.4244\/EIJY14M12_10","article-title":"Beyond the early stages: insights from the ASSURE registry on bioresorbable vascular scaffolds","volume":"11","author":"W\u00f6hrle","year":"2015","journal-title":"EuroIntervention"},{"key":"R26-13-20210204","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jcin.2014.11.010","article-title":"Bioresorbable drug-eluting stents: an immature technology in need of mature application","volume":"8","author":"Byrne","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"key":"R27-13-20210204","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S0140-6736(14)61455-0","article-title":"A bioresorbable everolimus-eluting scaffold versus a metallic everolimus-eluting stent for ischaemic heart disease caused by de-novo native coronary artery lesions (ABSORB II): an interim 1-year analysis of clinical and procedural secondary outcomes from a randomised controlled trial","volume":"385","author":"Serruys","year":"2015","journal-title":"Lancet"},{"key":"R29-13-20210204","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1016\/j.jacc.2015.09.054","article-title":"Bioresorbable vascular scaffolds versus metallic stents in patients with coronary artery disease: ABSORB China trial","volume":"66","author":"Gao","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R30-13-20210204","doi-asserted-by":"crossref","first-page":"3332","DOI":"10.1093\/eurheartj\/ehv435","article-title":"A randomized trial evaluating the everolimus-eluting Absorb bioresorbable scaffold vs. the everolimus-eluting metallic stent in patients with coronary artery disease: ABSORB Japan","volume":"36","author":"Kimura","year":"2015","journal-title":"Eur Heart J"},{"key":"R31-13-20210204","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1056\/NEJMoa1509038","article-title":"Everolimus-eluting bioresorbable scaffolds for coronary artery disease","volume":"373","author":"Ellis","year":"2015","journal-title":"N Engl J Med"},{"key":"R32-13-20210204","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.jacc.2014.12.017","article-title":"Comparison of everolimus- and biolimus-eluting coronary stents with everolimus-eluting bioresorbable vascular scaffolds","volume":"65","author":"Puricel","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R34-13-20210204","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1093\/eurheartj\/ehv500","article-title":"Everolimus-eluting bioresorbable stent vs. durable polymer everolimus-eluting metallic stent in patients with ST-segment elevation myocardial infarction: results of the randomized ABSORB ST-segment elevation myocardial infarction \u2013 TROFI II trial","volume":"37","author":"Sabat\u00e9","year":"2016","journal-title":"Eur Heart J"},{"key":"R35-13-20210204","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/S0140-6736(15)01039-9","article-title":"1-year outcomes with the Absorb bioresorbable scaffold in patients with coronary artery disease: a patient-level, pooled meta-analysis","volume":"387","author":"Stone","year":"2016","journal-title":"Lancet"},{"key":"R36-13-20210204","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S0140-6736(15)00979-4","article-title":"Everolimus-eluting bioresorbable vascular scaffolds versus everolimus-eluting metallic stents: a meta-analysis of randomised controlled trials","volume":"387","author":"Cassese","year":"2016","journal-title":"Lancet"},{"key":"R37-13-20210204","doi-asserted-by":"crossref","first-page":"752","DOI":"10.7326\/M16-0006","article-title":"Comparative efficacy and safety of everolimus-eluting bioresorbable scaffold versus everolimus-eluting metallic stents: a systematic review and meta-analysis","volume":"164","author":"Zhang","year":"2016","journal-title":"Ann Intern Med"},{"key":"R38-13-20210204","doi-asserted-by":"crossref","first-page":"E1643","DOI":"10.1016\/S0735-1097(13)61643-5","article-title":"The ABSORB COHORT B trial: insights from longitudinal imaging follow-up from six months to three years.","volume":"61","author":"Windecker","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"R39-13-20210204","doi-asserted-by":"crossref","first-page":"B181","DOI":"10.1016\/j.jacc.2014.07.684","article-title":"ABSORB Cohort B Trial: five year angiographic results of the ABSORB Everolimus eluting bioresorbable vascular scaffold","volume":"64","author":"De Bruyne","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R40-13-20210204","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.jacc.2015.11.060","article-title":"A polylactide bioresorbable scaffold eluting everolimus for treatment of coronary stenosis: 5-year follow-up","volume":"67","author":"Serruys","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R41-13-20210204","doi-asserted-by":"crossref","first-page":"2343","DOI":"10.1016\/j.jacc.2014.09.029","article-title":"OCT assessment of the long-term vascular healing response 5 years after everolimus-eluting bioresorbable vascular scaffold","volume":"64","author":"Karanasos","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"R42-13-20210204","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.atherosclerosis.2011.12.008","article-title":"Circumferential evaluation of the neointima by optical coherence tomography after ABSORB bioresorbable vascular scaffold implantation: can the scaffold cap the plaque?","volume":"221","author":"Brugaletta","year":"2012","journal-title":"Atherosclerosis"},{"key":"R44-13-20210204","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1016\/j.jacc.2015.10.002","article-title":"Bioresorbable scaffolds vs. metallic drug-eluting stents: are we getting any closer to a paradigm shift?","volume":"66","author":"Windecker","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"R45-13-20210204","doi-asserted-by":"crossref","first-page":"3343","DOI":"10.1093\/eurheartj\/ehv459","article-title":"Deliver the drug and be resorbed: evidence from ABSORB Japan","volume":"36","author":"Kristensen","year":"2015","journal-title":"Eur Heart J"},{"key":"R46-13-20210204","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.1056\/NEJMe1512331","article-title":"Bioresorbable vascular scaffolds \u2013 will promise become reality?","volume":"373","author":"Byrne","year":"2015","journal-title":"N Engl J Med"},{"key":"R47-13-20210204","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S0735-1097(16)30036-5","article-title":"Outcomes of the ABSORB bioresorbable vascular scaffold in very small and not very small coronary arteries: the ABSORB III randomized trial","volume":"67","author":"Stone","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R48-13-20210204","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2015.12.019","article-title":"Bioresorbable coronary scaffold thrombosis: multicenter comprehensive analysis of clinical presentation, mechanisms, and predictors","volume":"67","author":"Puricel","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"R49-13-20210204","doi-asserted-by":"crossref","first-page":"45","DOI":"10.4244\/EIJY15M01_05","article-title":"Contemporary practice and technical aspects in coronary intervention with bioresorbable scaffolds: a European perspective","volume":"11","author":"Tamburino","year":"2015","journal-title":"EuroIntervention"},{"key":"R50-13-20210204","first-page":"29","article-title":"Meta-analysis in medical research","volume":"14","author":"Haidich","year":"2010","journal-title":"Hippokratia"},{"key":"R51-13-20210204","doi-asserted-by":"crossref","first-page":"e1001855","DOI":"10.1371\/journal.pmed.1001855","article-title":"Individual participant data (IPD) meta-analyses of randomised controlled trials: guidance on their use","volume":"12","author":"Tierney","year":"2015","journal-title":"PLoS Med"}],"container-title":["Coronary Artery Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MCA.0000000000000414","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,5,14]],"date-time":"2021-05-14T02:40:58Z","timestamp":1620960058000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00019501-201701000-00013"}},"subtitle":["what have we learned from randomized-controlled clinical trials?"],"short-title":[],"issued":{"date-parts":[[2017,1]]},"references-count":48,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017]]}},"URL":"https:\/\/doi.org\/10.1097\/mca.0000000000000414","relation":{},"ISSN":["0954-6928"],"issn-type":[{"value":"0954-6928","type":"print"}],"subject":[],"published":{"date-parts":[[2017,1]]}}}